Product Information
GLIMEPIRIDE 1 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0239 per EA under NDC 42571010001. Its NADAC has been published 484 times since Nov 28, 2013.
FDA first approved this application on Jun 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Glimepiride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Micro Labs LimitedNDC
42571010001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091220FDA Approved
6/29/2012
TE Code
AB
On Market Since
6/13/2013
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 1 MG TABLET has been published 484 times since Nov 28, 2013, and over the history we have for it it has risen 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0239 per EA |
|---|---|
| All-time high | $0.0987 (Jan 13, 2016) |
| All-time low | $0.0184 (May 22, 2024) |
| 52-week high | $0.0255 |
| 52-week low | $0.0222 |
| Median price | $0.0340 |
| Average price | $0.0398 |
| Largest weekly change | +194.0% (Feb 18, 2015) |
| Weeks tracked | 484 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 1 MG TABLET, manufactured by Micro Labs Limited, is $0.0239 per EA (NDC 42571010001), effective Aug 19, 2026.
How has the price of GLIMEPIRIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 1 MG TABLET has risen 3.7%. It has been tracked across 484 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 1 MG TABLET?
Since Nov 28, 2013, the NADAC for GLIMEPIRIDE 1 MG TABLET has ranged from a low of $0.0184 (May 22, 2024) to a high of $0.0987 (Jan 13, 2016), with a median of $0.0340 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 1 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 1 MG TABLET, is $0.0222 per EA — about 7% below GLIMEPIRIDE 1 MG TABLET.
Who manufactures GLIMEPIRIDE 1 MG TABLET?
GLIMEPIRIDE 1 MG TABLET (NDC 42571010001) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.